Intravenous Immunoglobulins for the Treatment of Covid-19 Patients: a Clinical Trial
Clinical trial NCT04548557 · UNKNOWN
Trial details
- NCT number
- NCT04548557
- Sponsor
- University of Health Sciences Lahore
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-15
- Primary completion
- 2020-10-15
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.